Optimal Proteinuria Target for Renoprotection in Patients with IgA Nephropathy

Nam, Ki Heon; Kie, Jeong Hae; Lee, Mi Jung; Chang, Tae-Ik; Kang, Ea Wha; Kim, Dong Wook; Lim, Beom Jin; Park, Jung Tak; Kwon, Young Eun; Kim, Yung Ly; Park, Kyoung Sook; An, Seong Yeong; Oh, Hyung Jung; Yoo, Tae-Hyun; Kang, Shin-Wook; Choi, Kyu Hun; Jeong, Hyeon Joo; Han, Dae-Suk; Han, Seung Hyeok
July 2014
PLoS ONE;Jul2014, Vol. 9 Issue 7, p1
Academic Journal
Background: Proteinuria is a target for renoprotection in kidney diseases. However, optimal level of proteinuria reduction in IgA nephropathy (IgAN) is unknown. Methods: We conducted a retrospective observational study in 500 patients with biopsy-proven IgAN. Time-averaged proteinuria (TA-P) was calculated as the mean of every 6 month period of measurements of spot urine protein-to-creatinine ratio. The study endpoints were a 50% decline in estimated glomerular filtration rate (eGFR), onset of end-stage renal disease (ESRD), and slope of eGFR. Results: During a median follow-up duration of 65 (12–154) months, a 50% decline in eGFR occurred in 1 (0.8%) patient with TA-P of <0.3 g/g compared to 6 (2.7%) patients with TA-P of 0.3–0.99 g/g (hazard ratio, 2.82; P = 0.35). Risk of reaching a 50% decline in eGFR markedly increased in patients with TA-P of 1.0–2.99 g/g (P = 0.002) and those with TA-P≥3.0 g/g (P<0.001). ESRD did not occur in patients with TA-P<1.0 g/g compared to 26 (20.0%) and 8 (57.1%) patients with TA-P of 1.0–2.99 and ≥3.0 g/g, respectively. Kidney function of these two groups deteriorated faster than those with TA-P<1.0 g/g (P<0.001). However, patients with TA-P of 0.3–0.99 g/g had a greater decline of eGFR than patients with TA-P<0.3 g/g (−0.41±1.68 vs. −0.73±2.82 ml/min/1.73 m2/year, P = 0.03). Conclusion: In this study, patients with TA-P<1.0 g/g show favorable outcomes. However, given the faster eGFR decline in patients with TA-P of 0.3–0.99 g/g than in patients with TA-P<0.3 g/g, the ultimate optimal goal of proteinuria reduction can be lowered in the management of IgAN.


Related Articles

  • Influence of tonsillectomy on the progression of mesangioproliferative glomerulonephritis. Piccoli, Antonio; Codognotto, Marta; Tabbi, Maria-Grazia; Favaro, Enrico; Rossi, Barbara // Nephrology Dialysis Transplantation;Aug2010, Vol. 25 Issue 8, p2583 

    Background. Little information is available about the efficacy of tonsillectomy on long-term renal survival of patients with primary IgA nephropathy (IgAN).

  • Complete remission within 2 years predicts a good prognosis after methylprednisolone pulse therapy in patients with IgA nephropathy. Tatematsu, Miho; Yasuda, Yoshinari; Morita, Yoshiki; Sakamoto, Izumi; Kurata, Kei; Naruse, Tomohiko; Yamamoto, Rhohei; Tsuboi, Naotake; Sato, Waichi; Imai, Enyu; Matsuo, Seiichi; Maruyama, Shoichi // Clinical & Experimental Nephrology;Dec2012, Vol. 16 Issue 6, p883 

    Background: Pozzi et al. reported the effectiveness of steroid pulse therapy (Pozzi's regimen) in IgA nephropathy (IgAN). The present study was performed to clarify the predictive factors for IgAN patients treated with Pozzi's regimen. Methods: One hundred nine IgAN patients treated by Pozzi's...

  • Gender-Specific Outcome Differences Seen in CRD Progression.  // Kidney;Jan/Feb99, Vol. 8 Issue 1, p11 

    Presents the findings of a study which assessed gender differences in renal outcomes between men and women participating in the Modification Diet in Renal Disease (MDRD) study. Sex differences in terms of renal diagnoses, indications of proteinuria and serum creatinine levels; Observation that...

  • High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy. Peters, Hilde P.E.; Waanders, Femke; Meijer, Esther; van den Brand, Jan; Steenbergen, Eric J.; van Goor, Harry; Wetzels, Jack F.M. // Nephrology Dialysis Transplantation;Nov2011, Vol. 26 Issue 11, p3581 

    Background. The variable course of immunoglobulin A nephropathy (IgAN) warrants accurate tools for the prediction of progression. Urinary kidney injury molecule-1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) are markers for the detection of early tubular damage caused by various...

  • Prognostic indices and therapy in IgA nephropathy: Toward a solution. Ballardie, F. W.; Cowley, R. D. // Kidney International;Feb2008, Vol. 73 Issue 3, p249 

    IgA nephropathy is the primary renal disease with the greatest impact on services. The paucity of trials with high evidence-based standards gives emphasis to issues of the rationalization of therapies. Now that certain treatments are increasingly accepted and others under evaluation, reliable...

  • Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. Coppo, Rosanna; Troyanov, Stéphan; Bellur, Shubha; Cattran, Daniel; Cook, H Terence; Feehally, John; Roberts, Ian S D; Morando, Laura; Camilla, Roberta; Tesar, Vladimir; Lunberg, Sigrid; Gesualdo, Loreto; Emma, Francesco; Rollino, Cristiana; Amore, Alessandro; Praga, Manuel; Feriozzi, Sandro; Segoloni, Giuseppe; Pani, Antonello; Cancarini, Giovanni // Kidney International;Oct2014, Vol. 86 Issue 4, p828 

    The Oxford Classification of IgA Nephropathy (IgAN) identified mesangial hypercellularity (M), endocapillary proliferation (E), segmental glomerulosclerosis (S), and tubular atrophy/interstitial fibrosis (T) as independent predictors of outcome. Whether it applies to individuals excluded from...

  • Clinical validation of immunoglobulin A nephropathy diagnosis in Swedish biopsy registers. Jarrick, Simon; Lundberg, Sigrid; Welander, Adina; Fored, C. Michael; Ludvigsson, Jonas F. // Clinical Epidemiology;Jan2017, Vol. 9, p67 

    Aims: The aims of this study were to validate the diagnosis of IgA nephropathy (IgAN) in Swedish biopsy registers against patient charts and to describe the clinical characteristics of patients with a biopsy indicating IgAN. Methods: This is a population-based cohort study. Out of 4,069...

  • Low glomerular density is a risk factor for progression in idiopathic membranous nephropathy. Tsuboi, Nobuo; Kawamura, Tetsuya; Miyazaki, Yoichi; Utsunomiya, Yasunori; Hosoya, Tatsuo // Nephrology Dialysis Transplantation;Nov2011, Vol. 26 Issue 11, p3555 

    Background. The adverse histological features predicting a progressive loss of renal function in idiopathic membranous nephropathy (IMN), before the establishment of impaired renal function with advanced glomerulosclerosis and/or interstitial fibrosis, are still poorly understood. The present...

  • Creatinine Clearance and Estimated Glomerular Filtration Rate - When are they Interchangeable. Šimetić, Lucija; Zibar, Lada; Drmić, Sandra; Begić, Ivana; Šerić, Vatroslav // Collegium Antropologicum;2015, Vol. 39 Issue 3, p735 

    Study goal was to examine which of glomerular rate equations is most suitable for prediction of creatinine clearance (CrCl). Using a retrospective review of data from 500 hospital patients we calculated glomerular filtration rate according to Cockcroft-Gault equation (C-G), Modification of Diet...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics